Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	H3K27me3 modified histone binding	TAF1 TAF1L	2.18e-05	5	30	2	GO:0061628
GeneOntologyMolecularFunction	SH3 domain binding	NCF1C NCF1B CD2AP SH3KBP1	5.98e-05	143	30	4	GO:0017124
GeneOntologyMolecularFunction	RNA polymerase I general transcription initiation factor activity	TAF1 TAF1L	7.80e-05	9	30	2	GO:0001181
GeneOntologyMolecularFunction	superoxide-generating NADPH oxidase activator activity	NCF1C NCF1B	9.75e-05	10	30	2	GO:0016176
GeneOntologyMolecularFunction	superoxide-generating NAD(P)H oxidase activity	NCF1C NCF1B	1.43e-04	12	30	2	GO:0016175
GeneOntologyMolecularFunction	methylated histone binding	ZMYND11 TAF1 TAF1L	2.88e-04	86	30	3	GO:0035064
GeneOntologyMolecularFunction	methylation-dependent protein binding	ZMYND11 TAF1 TAF1L	3.08e-04	88	30	3	GO:0140034
GeneOntologyMolecularFunction	oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor	NCF1C NCF1B	4.08e-04	20	30	2	GO:0050664
GeneOntologyMolecularFunction	RNA polymerase II core promoter sequence-specific DNA binding	TAF1 TAF1L	6.41e-04	25	30	2	GO:0000979
GeneOntologyMolecularFunction	RNA polymerase II general transcription initiation factor binding	TAF1 TAF1L	7.48e-04	27	30	2	GO:0001091
GeneOntologyMolecularFunction	lysine-acetylated histone binding	TAF1 TAF1L	9.25e-04	30	30	2	GO:0070577
GeneOntologyMolecularFunction	acetylation-dependent protein binding	TAF1 TAF1L	9.88e-04	31	30	2	GO:0140033
GeneOntologyMolecularFunction	TBP-class protein binding	TAF1 TAF1L	1.12e-03	33	30	2	GO:0017025
GeneOntologyMolecularFunction	phosphatidylinositol binding	NCF1C NCF1B MYO10 ASAP1	1.22e-03	316	30	4	GO:0035091
GeneOntologyMolecularFunction	phosphatidylinositol-3,4-bisphosphate binding	NCF1C NCF1B	1.26e-03	35	30	2	GO:0043325
GeneOntologyMolecularFunction	transcription regulator inhibitor activity	TAF1 TAF1L	1.33e-03	36	30	2	GO:0140416
GeneOntologyMolecularFunction	ubiquitin conjugating enzyme activity	TAF1 TAF1L	1.41e-03	37	30	2	GO:0061631
GeneOntologyMolecularFunction	gamma-tubulin binding	DIXDC1 ARHGEF7	1.48e-03	38	30	2	GO:0043015
GeneOntologyMolecularFunction	protein domain specific binding	CARD10 DIXDC1 NCF1C NCF1B CD2AP SH3KBP1	1.67e-03	875	30	6	GO:0019904
GeneOntologyMolecularFunction	ubiquitin-like protein conjugating enzyme activity	TAF1 TAF1L	1.90e-03	43	30	2	GO:0061650
GeneOntologyMolecularFunction	phosphatidylinositol-3,4,5-trisphosphate binding	MYO10 ASAP1	2.46e-03	49	30	2	GO:0005547
GeneOntologyMolecularFunction	histone acetyltransferase activity	TAF1 TAF1L	2.66e-03	51	30	2	GO:0004402
GeneOntologyMolecularFunction	enzyme activator activity	ASAP2 NCF1C NCF1B PREX2 ASAP1	2.72e-03	656	30	5	GO:0008047
GeneOntologyMolecularFunction	RNA polymerase II general transcription initiation factor activity	TAF1 TAF1L	2.76e-03	52	30	2	GO:0016251
GeneOntologyMolecularFunction	core promoter sequence-specific DNA binding	TAF1 TAF1L	3.08e-03	55	30	2	GO:0001046
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	TAF1 TAF1L	3.08e-03	55	30	2	GO:0061733
GeneOntologyMolecularFunction	lipid binding	C3 LIPC NCF1C NCF1B MYO10 ASAP1	3.09e-03	988	30	6	GO:0008289
GeneOntologyMolecularFunction	modification-dependent protein binding	ZMYND11 TAF1 TAF1L	3.58e-03	206	30	3	GO:0140030
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	TAF1 TAF1L	3.66e-03	60	30	2	GO:0034212
GeneOntologyMolecularFunction	general transcription initiation factor binding	TAF1 TAF1L	4.15e-03	64	30	2	GO:0140296
GeneOntologyMolecularFunction	enzyme regulator activity	C3 ASAP2 NCF1C NCF1B ARHGEF7 PREX2 ASAP1	4.29e-03	1418	30	7	GO:0030234
GeneOntologyMolecularFunction	basal RNA polymerase II transcription machinery binding	TAF1 TAF1L	4.41e-03	66	30	2	GO:0001099
GeneOntologyMolecularFunction	basal transcription machinery binding	TAF1 TAF1L	4.41e-03	66	30	2	GO:0001098
GeneOntologyMolecularFunction	general transcription initiation factor activity	TAF1 TAF1L	4.67e-03	68	30	2	GO:0140223
GeneOntologyMolecularFunction	actin filament binding	PSTPIP1 MYO10 CD2AP	4.69e-03	227	30	3	GO:0051015
GeneOntologyMolecularFunction	actin binding	DIXDC1 PSTPIP1 MYO10 CD2AP	5.47e-03	479	30	4	GO:0003779
GeneOntologyMolecularFunction	p53 binding	TAF1 TAF1L	5.95e-03	77	30	2	GO:0002039
GeneOntologyMolecularFunction	N-acetyltransferase activity	TAF1 TAF1L	6.10e-03	78	30	2	GO:0008080
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	ASAP2 ARHGEF7 PREX2 ASAP1	6.67e-03	507	30	4	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	ASAP2 ARHGEF7 PREX2 ASAP1	6.67e-03	507	30	4	GO:0030695
GeneOntologyMolecularFunction	promoter-specific chromatin binding	TAF1 TAF1L	6.89e-03	83	30	2	GO:1990841
GeneOntologyMolecularFunction	histone binding	ZMYND11 TAF1 TAF1L	7.20e-03	265	30	3	GO:0042393
GeneOntologyMolecularFunction	GTPase activator activity	ASAP2 PREX2 ASAP1	8.29e-03	279	30	3	GO:0005096
GeneOntologyMolecularFunction	phospholipid binding	NCF1C NCF1B MYO10 ASAP1	8.73e-03	548	30	4	GO:0005543
GeneOntologyMolecularFunction	oxidoreductase activity, acting on NAD(P)H	NCF1C NCF1B	8.93e-03	95	30	2	GO:0016651
GeneOntologyMolecularFunction	N-acyltransferase activity	TAF1 TAF1L	1.02e-02	102	30	2	GO:0016410
GeneOntologyMolecularFunction	acetyltransferase activity	TAF1 TAF1L	1.06e-02	104	30	2	GO:0016407
GeneOntologyMolecularFunction	sulfur compound binding	LIPC TAF1 P2RX1	1.23e-02	323	30	3	GO:1901681
GeneOntologyBiologicalProcess	neutrophil-mediated killing of gram-positive bacterium	NCF1C NCF1B	2.04e-05	5	30	2	GO:0070946
GeneOntologyBiologicalProcess	neutrophil-mediated killing of fungus	NCF1C NCF1B	4.28e-05	7	30	2	GO:0070947
GeneOntologyBiologicalProcess	NADP catabolic process	NCF1C NCF1B	4.28e-05	7	30	2	GO:0006742
GeneOntologyBiologicalProcess	regulation of respiratory burst involved in inflammatory response	NCF1C NCF1B	1.12e-04	11	30	2	GO:0060264
GeneOntologyBiologicalProcess	respiratory burst involved in inflammatory response	NCF1C NCF1B	1.58e-04	13	30	2	GO:0002536
GeneOntologyBiologicalProcess	regulation of smooth muscle contraction	P2RX1 NCF1C NCF1B	2.04e-04	79	30	3	GO:0006940
GeneOntologyBiologicalProcess	neutrophil-mediated killing of bacterium	NCF1C NCF1B	2.42e-04	16	30	2	GO:0070944
GeneOntologyBiologicalProcess	response to yeast	NCF1C NCF1B	3.08e-04	18	30	2	GO:0001878
GeneOntologyBiologicalProcess	neutrophil-mediated killing of symbiont cell	NCF1C NCF1B	3.44e-04	19	30	2	GO:0070943
GeneOntologyBiologicalProcess	respiratory burst involved in defense response	NCF1C NCF1B	3.82e-04	20	30	2	GO:0002679
GeneOntologyBiologicalProcess	positive regulation of GTPase activity	ASAP2 ARHGEF7 PREX2 ASAP1	4.11e-04	244	30	4	GO:0043547
GeneOntologyBiologicalProcess	neutrophil mediated cytotoxicity	NCF1C NCF1B	4.22e-04	21	30	2	GO:0070942
GeneOntologyBiologicalProcess	negative regulation of smooth muscle contraction	NCF1C NCF1B	4.64e-04	22	30	2	GO:0045986
GeneOntologyBiologicalProcess	hydrogen peroxide biosynthetic process	NCF1C NCF1B	4.64e-04	22	30	2	GO:0050665
GeneOntologyBiologicalProcess	regulation of respiratory burst	NCF1C NCF1B	5.08e-04	23	30	2	GO:0060263
GeneOntologyBiologicalProcess	positive regulation of hydrolase activity	ASAP2 P2RX1 ARHGEF7 PREX2 ASAP1	7.02e-04	499	30	5	GO:0051345
GeneOntologyCellularComponent	actin cytoskeleton	ACTL7A DIXDC1 PSTPIP1 MYO10 CD2AP ASAP1	1.44e-04	576	30	6	GO:0015629
GeneOntologyCellularComponent	NADPH oxidase complex	NCF1C NCF1B	3.00e-04	18	30	2	GO:0043020
GeneOntologyCellularComponent	pronucleus	TAF1 TAF1L	7.35e-04	28	30	2	GO:0045120
GeneOntologyCellularComponent	MLL1 complex	TAF1 TAF1L	9.61e-04	32	30	2	GO:0071339
GeneOntologyCellularComponent	MLL1/2 complex	TAF1 TAF1L	1.02e-03	33	30	2	GO:0044665
GeneOntologyCellularComponent	secretory granule membrane	ATP8A1 P2RX1 ANPEP CFAP65	1.20e-03	329	30	4	GO:0030667
GeneOntologyCellularComponent	somatodendritic compartment	DIXDC1 NCF1C NCF1B ARHGEF7 MYO10 CD2AP ASAP1	1.46e-03	1228	30	7	GO:0036477
GeneOntologyCellularComponent	podosome	CD2AP ASAP1	1.58e-03	41	30	2	GO:0002102
GeneOntologyCellularComponent	cell cortex	PSTPIP1 ARHGEF7 MYO10 CD2AP	1.86e-03	371	30	4	GO:0005938
GeneOntologyCellularComponent	transcription factor TFIID complex	TAF1 TAF1L	2.07e-03	47	30	2	GO:0005669
GeneOntologyCellularComponent	secretory granule	ACTL7A C3 ATP8A1 P2RX1 ANPEP CFAP65	2.80e-03	1014	30	6	GO:0030141
GeneOntologyCellularComponent	ruffle	ARHGEF7 MYO10 CD2AP	3.15e-03	206	30	3	GO:0001726
GeneOntologyCellularComponent	Golgi apparatus subcompartment	ASAP2 ATP8A1 CD2AP ASAP1	3.52e-03	443	30	4	GO:0098791
MousePheno	increased angiotensin I-converting enzyme activity	NCF1C NCF1B	5.77e-05	6	28	2	MP:0003184
MousePheno	abnormal angiotensin I-converting enzyme activity	NCF1C NCF1B	5.77e-05	6	28	2	MP:0013254
MousePheno	liver abscess	NCF1C NCF1B	8.07e-05	7	28	2	MP:0003332
MousePheno	impaired granulocyte bactericidal activity	NCF1C NCF1B	1.72e-04	10	28	2	MP:0005074
Domain	SH3_1	ASAP2 PSTPIP1 ARHGEF7 CD2AP ASAP1 SH3KBP1	1.34e-07	164	28	6	PF00018
Domain	SH3	ASAP2 PSTPIP1 ARHGEF7 CD2AP ASAP1 SH3KBP1	6.80e-07	216	28	6	PS50002
Domain	SH3	ASAP2 PSTPIP1 ARHGEF7 CD2AP ASAP1 SH3KBP1	6.80e-07	216	28	6	SM00326
Domain	SH3_domain	ASAP2 PSTPIP1 ARHGEF7 CD2AP ASAP1 SH3KBP1	7.57e-07	220	28	6	IPR001452
Domain	TAF_II_230-bd	TAF1 TAF1L	2.17e-06	2	28	2	IPR009067
Domain	DUF3591	TAF1 TAF1L	2.17e-06	2	28	2	PF12157
Domain	TFIID_sub1_DUF3591	TAF1 TAF1L	2.17e-06	2	28	2	IPR022591
Domain	-	TAF1 TAF1L	2.17e-06	2	28	2	1.10.1100.10
Domain	TBP-binding	TAF1 TAF1L	2.17e-06	2	28	2	PF09247
Domain	TAF1_animal	TAF1 TAF1L	2.17e-06	2	28	2	IPR011177
Domain	SH3_9	ASAP2 PSTPIP1 CD2AP SH3KBP1	5.34e-06	78	28	4	PF14604
Domain	PH	ASAP2 ARHGEF7 MYO10 PREX2 ASAP1	2.07e-05	229	28	5	PF00169
Domain	Bromodomain	ZMYND11 TAF1 TAF1L	2.46e-05	38	28	3	PF00439
Domain	BROMODOMAIN_2	ZMYND11 TAF1 TAF1L	3.10e-05	41	28	3	PS50014
Domain	BROMO	ZMYND11 TAF1 TAF1L	3.33e-05	42	28	3	SM00297
Domain	Bromodomain	ZMYND11 TAF1 TAF1L	3.33e-05	42	28	3	IPR001487
Domain	-	ZMYND11 TAF1 TAF1L	3.33e-05	42	28	3	1.20.920.10
Domain	PH	ASAP2 ARHGEF7 MYO10 PREX2 ASAP1	5.23e-05	278	28	5	SM00233
Domain	PH_DOMAIN	ASAP2 ARHGEF7 MYO10 PREX2 ASAP1	5.32e-05	279	28	5	PS50003
Domain	PH_domain	ASAP2 ARHGEF7 MYO10 PREX2 ASAP1	5.41e-05	280	28	5	IPR001849
Domain	-	ASAP2 ARHGEF7 MYO10 PREX2 ASAP1	2.59e-04	391	28	5	2.30.29.30
Domain	SH3_2	ARHGEF7 CD2AP SH3KBP1	2.84e-04	86	28	3	IPR011511
Domain	SH3_2	ARHGEF7 CD2AP SH3KBP1	2.84e-04	86	28	3	PF07653
Domain	PH_dom-like	ASAP2 ARHGEF7 MYO10 PREX2 ASAP1	3.84e-04	426	28	5	IPR011993
Domain	Bromodomain_CS	TAF1 TAF1L	6.89e-04	26	28	2	IPR018359
Domain	ArfGap	ASAP2 ASAP1	8.58e-04	29	28	2	SM00105
Domain	ARFGAP	ASAP2 ASAP1	8.58e-04	29	28	2	PS50115
Domain	ArfGAP	ASAP2 ASAP1	8.58e-04	29	28	2	IPR001164
Domain	ArfGap	ASAP2 ASAP1	8.58e-04	29	28	2	PF01412
Domain	-	ASAP2 ASAP1	9.19e-04	30	28	2	1.20.1270.60
Domain	AH/BAR-dom	ASAP2 ASAP1	9.19e-04	30	28	2	IPR027267
Domain	BROMODOMAIN_1	TAF1 TAF1L	1.40e-03	37	28	2	PS00633
Domain	GDS_CDC24_CS	ARHGEF7 PREX2	1.55e-03	39	28	2	IPR001331
Domain	Ank_2	ASAP2 HECTD1 ASAP1	3.99e-03	215	28	3	PF12796
Domain	DH_1	ARHGEF7 PREX2	4.00e-03	63	28	2	PS00741
Domain	CH	DIXDC1 ARHGEF7	4.25e-03	65	28	2	SM00033
Domain	RhoGEF	ARHGEF7 PREX2	4.64e-03	68	28	2	SM00325
Domain	Ank	ASAP2 HECTD1 ASAP1	4.70e-03	228	28	3	PF00023
Domain	DH_2	ARHGEF7 PREX2	4.91e-03	70	28	2	PS50010
Domain	RhoGEF	ARHGEF7 PREX2	4.91e-03	70	28	2	PF00621
Domain	CH	DIXDC1 ARHGEF7	4.91e-03	70	28	2	PF00307
Domain	DH-domain	ARHGEF7 PREX2	5.05e-03	71	28	2	IPR000219
Domain	-	ARHGEF7 PREX2	5.05e-03	71	28	2	1.20.900.10
Domain	-	DIXDC1 ARHGEF7	5.05e-03	71	28	2	1.10.418.10
Domain	CH	DIXDC1 ARHGEF7	5.33e-03	73	28	2	PS50021
Domain	CH-domain	DIXDC1 ARHGEF7	5.62e-03	75	28	2	IPR001715
Domain	-	ASAP2 HECTD1 ASAP1	5.93e-03	248	28	3	1.25.40.20
Domain	ANK	ASAP2 HECTD1 ASAP1	6.13e-03	251	28	3	SM00248
Domain	ANK_REPEAT	ASAP2 HECTD1 ASAP1	6.27e-03	253	28	3	PS50088
Domain	Ankyrin_rpt-contain_dom	ASAP2 HECTD1 ASAP1	6.33e-03	254	28	3	IPR020683
Domain	ANK_REP_REGION	ASAP2 HECTD1 ASAP1	6.33e-03	254	28	3	PS50297
Domain	Ankyrin_rpt	ASAP2 HECTD1 ASAP1	6.90e-03	262	28	3	IPR002110
Pathway	REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES	NCF1C NCF1B	9.10e-05	9	23	2	MM14524
Pathway	REACTOME_INNATE_IMMUNE_SYSTEM	C3 PSTPIP1 ATP8A1 P2RX1 ANPEP NCF1C NCF1B MYO10	1.13e-04	995	23	8	MM14661
Pathway	REACTOME_RAC1_GTPASE_CYCLE	NCF1C NCF1B ARHGEF7 PREX2	1.69e-04	175	23	4	MM15599
Pathway	BIOCARTA_ARAP_PATHWAY	ASAP2 ASAP1	3.41e-04	17	23	2	M2482
Pathway	WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY	ANPEP NCF1C NCF1B	4.33e-04	92	23	3	MM15823
Pathway	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	ASAP2 MYO10 ASAP1	4.91e-04	96	23	3	M16121
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES	NCF1C NCF1B	7.47e-04	25	23	2	MM15269
Pathway	REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION	C3 PSTPIP1	8.08e-04	26	23	2	M29838
Pathway	REACTOME_EGFR_DOWNREGULATION	ARHGEF7 SH3KBP1	1.15e-03	31	23	2	MM14705
Pathway	REACTOME_EGFR_DOWNREGULATION	ARHGEF7 SH3KBP1	1.15e-03	31	23	2	M16597
Pathway	BIOCARTA_FMLP_PATHWAY	NCF1C NCF1B	1.38e-03	34	23	2	MM1399
Pathway	KEGG_BASAL_TRANSCRIPTION_FACTORS	TAF1 TAF1L	1.47e-03	35	23	2	M4864
Pathway	REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES	NCF1C NCF1B	1.47e-03	35	23	2	MM14944
Pathway	PID_RAC1_REG_PATHWAY	ARHGEF7 PREX2	1.73e-03	38	23	2	M241
Pathway	REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES	NCF1C NCF1B	1.73e-03	38	23	2	MM14519
Pathway	PID_ERBB1_INTERNALIZATION_PATHWAY	ARHGEF7 SH3KBP1	2.01e-03	41	23	2	M214
Pathway	WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY	NCF1C NCF1B	2.52e-03	46	23	2	MM15837
Pathway	WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME	TAF1 TAF1L	2.52e-03	46	23	2	MM15949
Pathway	REACTOME_HIV_TRANSCRIPTION_INITIATION	TAF1 TAF1L	2.63e-03	47	23	2	M29568
Pathway	REACTOME_RNA_POLYMERASE_II_PROMOTER_ESCAPE	TAF1 TAF1L	2.74e-03	48	23	2	MM15424
Pathway	REACTOME_SIGNALING_BY_EGFR	ARHGEF7 SH3KBP1	2.86e-03	49	23	2	MM14695
Pathway	KEGG_ENDOCYTOSIS	ASAP2 ASAP1 SH3KBP1	3.05e-03	181	23	3	M1519
Pathway	REACTOME_SIGNALING_BY_EGFR	ARHGEF7 SH3KBP1	3.34e-03	53	23	2	M27039
Pubmed	CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery.	ASAP2 ASAP1 SH3KBP1	2.24e-08	7	31	3	17255943
Pubmed	Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities.	ASAP2 ASAP1 SH3KBP1	3.58e-08	8	31	3	15719014
Pubmed	Neutrophil-activating therapy for the treatment of cancer.	C3 NCF1C NCF1B	1.05e-07	11	31	3	36706760
Pubmed	Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders.	TAF1 TAF1L	7.69e-07	2	31	2	38804708
Pubmed	CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes.	CD2AP SH3KBP1	7.69e-07	2	31	2	27531950
Pubmed	Functional pseudogenes inhibit the superoxide production.	NCF1C NCF1B	7.69e-07	2	31	2	26086043
Pubmed	TAFII250, Egr-1, and D-type cyclin expression in mice and neonatal rat cardiomyocytes treated with doxorubicin.	TAF1 TAF1L	7.69e-07	2	31	2	10070062
Pubmed	Sustained expression of a neuron-specific isoform of the Taf1 gene in development stages and aging in mice.	TAF1 TAF1L	7.69e-07	2	31	2	22842574
Pubmed	CD2AP/CIN85 balance determines receptor tyrosine kinase signaling response in podocytes.	CD2AP SH3KBP1	7.69e-07	2	31	2	17213204
Pubmed	Frameshift Mutations in the Mononucleotide Repeats of TAF1 and TAF1L Genes in Gastric and Colorectal Cancers with Regional Heterogeneity.	TAF1 TAF1L	7.69e-07	2	31	2	27571988
Pubmed	Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 Isoforms.	TAF1 TAF1L	7.69e-07	2	31	2	34403156
Pubmed	Identification of novel SH3 domain ligands for the Src family kinase Hck. Wiskott-Aldrich syndrome protein (WASP), WASP-interacting protein (WIP), and ELMO1.	CD2AP ASAP1 SH3KBP1	1.46e-06	25	31	3	12029088
Pubmed	Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor.	ASAP2 ARHGEF7 CD2AP ASAP1	2.15e-06	103	31	4	21706016
Pubmed	Direct interaction of HIV gp120 with neuronal CXCR4 and CCR5 receptors induces cofilin-actin rod pathology via a cellular prion protein- and NOX-dependent mechanism.	NCF1C NCF1B	2.31e-06	3	31	2	33705493
Pubmed	Reactive oxygen species and p47phox activation are essential for the Mycobacterium tuberculosis-induced pro-inflammatory response in murine microglia.	NCF1C NCF1B	2.31e-06	3	31	2	18036262
Pubmed	Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis.	NCF1C NCF1B	2.31e-06	3	31	2	23965970
Pubmed	Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice.	NCF1C NCF1B	2.31e-06	3	31	2	10678931
Pubmed	Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome.	NCF1C NCF1B	2.31e-06	3	31	2	27044504
Pubmed	Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species.	NCF1C NCF1B	2.31e-06	3	31	2	17167081
Pubmed	Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors.	NCF1C NCF1B	2.31e-06	3	31	2	24358335
Pubmed	Molecular characterization of the mouse p47-phox (Ncf1) gene and comparative analysis of the mouse p47-phox (Ncf1) gene to the human NCF1 gene.	NCF1C NCF1B	2.31e-06	3	31	2	10891396
Pubmed	P47phox-/- mice are compromised in expansion and activation of CD8+ T cells and susceptible to Trypanosoma cruzi infection.	NCF1C NCF1B	2.31e-06	3	31	2	25474113
Pubmed	NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury.	NCF1C NCF1B	2.31e-06	3	31	2	18787174
Pubmed	NAD(P)H oxidase subunit p47phox is elevated, and p47phox knockout prevents diaphragm contractile dysfunction in heart failure.	NCF1C NCF1B	2.31e-06	3	31	2	26209274
Pubmed	Deficient production of reactive oxygen species leads to severe chronic DSS-induced colitis in Ncf1/p47phox-mutant mice.	NCF1C NCF1B	2.31e-06	3	31	2	24873968
Pubmed	p47(phox) is required for afferent arteriolar contractile responses to angiotensin II and perfusion pressure in mice.	NCF1C NCF1B	2.31e-06	3	31	2	22184329
Pubmed	Macrophage-derived reactive oxygen species protects against autoimmune priming with a defined polymeric adjuvant.	NCF1C NCF1B	2.31e-06	3	31	2	26455429
Pubmed	Superoxide generation from Kupffer cells contributes to hepatocarcinogenesis: studies on NADPH oxidase knockout mice.	NCF1C NCF1B	2.31e-06	3	31	2	15513930
Pubmed	NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease.	NCF1C NCF1B	2.31e-06	3	31	2	11018074
Pubmed	Conditional haploinsufficiency of NCF1 (encoding p47(phox)), a signaling gene with a heterozygous phenotype potentially subject to natural selection.	NCF1C NCF1B	2.31e-06	3	31	2	15626477
Pubmed	Phosphoinositide 3-kinase regulates the phosphorylation of NADPH oxidase component p47(phox) by controlling cPKC/PKCdelta but not Akt.	NCF1C NCF1B	2.31e-06	3	31	2	15033459
Pubmed	Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis.	NCF1C NCF1B	2.31e-06	3	31	2	33545139
Pubmed	Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis.	NCF1C NCF1B	2.31e-06	3	31	2	20142487
Pubmed	Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease.	NCF1C NCF1B	2.31e-06	3	31	2	9116268
Pubmed	Mice producing less reactive oxygen species are relatively resistant to collagen glycopeptide vaccination against arthritis.	NCF1C NCF1B	2.31e-06	3	31	2	20686129
Pubmed	NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity.	NCF1C NCF1B	2.31e-06	3	31	2	19077231
Pubmed	Neutrophil-derived ROS contribute to oxidative DNA damage induction by quartz particles.	NCF1C NCF1B	2.31e-06	3	31	2	20828610
Pubmed	p47phox Phox homology domain regulates plasma membrane but not phagosome neutrophil NADPH oxidase activation.	NCF1C NCF1B	2.31e-06	3	31	2	20817944
Pubmed	Angiotensin II induced catabolic effect and muscle atrophy are redox dependent.	NCF1C NCF1B	2.31e-06	3	31	2	21570954
Pubmed	p47(phox) contributes to albuminuria and kidney fibrosis in mice.	NCF1C NCF1B	2.31e-06	3	31	2	25565313
Pubmed	Reduction of NADPH-oxidase activity ameliorates the cardiovascular phenotype in a mouse model of Williams-Beuren Syndrome.	NCF1C NCF1B	2.31e-06	3	31	2	22319452
Pubmed	Early determinants of H2O2-induced endothelial dysfunction.	NCF1C NCF1B	2.31e-06	3	31	2	16895801
Pubmed	Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis.	NCF1C NCF1B	2.31e-06	3	31	2	20690191
Pubmed	Endosomal acidification and activation of NADPH oxidase isoforms are upstream events in hyperosmolarity-induced hepatocyte apoptosis.	NCF1C NCF1B	2.31e-06	3	31	2	16772302
Pubmed	Distinct ubiquitin binding modes exhibited by SH3 domains: molecular determinants and functional implications.	CD2AP SH3KBP1	2.31e-06	3	31	2	24039852
Pubmed	Knockout of neutrophil cytosolic factor 1 ameliorates neuroinflammation and motor deficit after traumatic brain injury.	NCF1C NCF1B	2.31e-06	3	31	2	39357591
Pubmed	Aging increases vulnerability to stress-induced depression via upregulation of NADPH oxidase in mice.	NCF1C NCF1B	2.31e-06	3	31	2	32504071
Pubmed	Effect of p47phox gene deletion on ROS production and oxygen sensing in mouse carotid body chemoreceptor cells.	NCF1C NCF1B	2.31e-06	3	31	2	16280459
Pubmed	Inhibition of T cell activation and function by the adaptor protein CIN85.	CD2AP SH3KBP1	2.31e-06	3	31	2	30723173
Pubmed	Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.	NCF1C NCF1B	2.31e-06	3	31	2	18185592
Pubmed	Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion.	NCF1C NCF1B	2.31e-06	3	31	2	12958309
Pubmed	Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells.	NCF1C NCF1B	2.31e-06	3	31	2	11435342
Pubmed	Neutrophil Cytosolic Factor 1 in Dendritic Cells Promotes Autoreactive CD8+ T Cell Activation via Cross-Presentation in Type 1 Diabetes.	NCF1C NCF1B	2.31e-06	3	31	2	31118934
Pubmed	Female mice lacking p47phox have altered adipose tissue gene expression and are protected against high fat-induced obesity.	NCF1C NCF1B	2.31e-06	3	31	2	23482812
Pubmed	NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions.	NCF1C NCF1B	2.31e-06	3	31	2	36853827
Pubmed	Prolonged production of reactive oxygen species in response to B cell receptor stimulation promotes B cell activation and proliferation.	NCF1C NCF1B	2.31e-06	3	31	2	23024271
Pubmed	Virulence comparisons of Aspergillus nidulans mutants are confounded by the inflammatory response of p47phox-/- mice.	NCF1C NCF1B	2.31e-06	3	31	2	16041040
Pubmed	The p47(phox-/-) mouse model of chronic granulomatous disease has normal granuloma formation and cytokine responses to Mycobacterium avium and Schistosoma mansoni eggs.	NCF1C NCF1B	2.31e-06	3	31	2	10085000
Pubmed	The Pro-Oncogenic Adaptor CIN85 Acts as an Inhibitory Binding Partner of Hypoxia-Inducible Factor Prolyl Hydroxylase 2.	CD2AP SH3KBP1	2.31e-06	3	31	2	31142511
Pubmed	Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators.	NCF1C NCF1B	2.31e-06	3	31	2	10987289
Pubmed	Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells.	NCF1C NCF1B	2.31e-06	3	31	2	21253614
Pubmed	TAFII55 binding to TAFII250 inhibits its acetyltransferase activity.	TAF1 TAF1L	2.31e-06	3	31	2	11592977
Pubmed	CFBP is a novel tyrosine-phosphorylated protein that might function as a regulator of CIN85/CD2AP.	CD2AP SH3KBP1	2.31e-06	3	31	2	16895919
Pubmed	Methamphetamine alters occludin expression via NADPH oxidase-induced oxidative insult and intact caveolae.	NCF1C NCF1B	2.31e-06	3	31	2	21435178
Pubmed	Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.	NCF1C NCF1B	2.31e-06	3	31	2	25873172
Pubmed	Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene.	NCF1C NCF1B	2.31e-06	3	31	2	15310853
Pubmed	Intermittent hypoxia has organ-specific effects on oxidative stress.	NCF1C NCF1B	2.31e-06	3	31	2	18703411
Pubmed	Mycobacterial infection induces higher interleukin-1β and dysregulated lung inflammation in mice with defective leukocyte NADPH oxidase.	NCF1C NCF1B	2.31e-06	3	31	2	29228045
Pubmed	Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion.	NCF1C NCF1B	2.31e-06	3	31	2	17307863
Pubmed	Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21.	NCF1C NCF1B	2.31e-06	3	31	2	31393787
Pubmed	Vascular effects following homozygous disruption of p47(phox) : An essential component of NADPH oxidase.	NCF1C NCF1B	2.31e-06	3	31	2	10725280
Pubmed	Generation of reactive oxygen species (ROS) is a key factor for stimulation of macrophage proliferation by ceramide 1-phosphate.	NCF1C NCF1B	2.31e-06	3	31	2	22155727
Pubmed	Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss.	NCF1C NCF1B	2.31e-06	3	31	2	27829407
Pubmed	Ncf1 Governs Immune Niches in the Lung to Mediate Pulmonary Inflammation in Mice.	NCF1C NCF1B	2.31e-06	3	31	2	34970267
Pubmed	Germ-free mice deficient of reactive oxygen species have increased arthritis susceptibility.	NCF1C NCF1B	2.31e-06	3	31	2	25689796
Pubmed	Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunction.	NCF1C NCF1B	2.31e-06	3	31	2	24576409
Pubmed	The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis.	NCF1C NCF1B	2.31e-06	3	31	2	22376231
Pubmed	Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation.	NCF1C NCF1B	2.31e-06	3	31	2	14993144
Pubmed	Leishmania amazonensis amastigotes trigger neutrophil activation but resist neutrophil microbicidal mechanisms.	NCF1C NCF1B	2.31e-06	3	31	2	23918780
Pubmed	NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells.	NCF1C NCF1B	2.31e-06	3	31	2	28274989
Pubmed	The p47phox deficiency significantly attenuates the pathogenicity of Chlamydia muridarum in the mouse oviduct but not uterine tissues.	NCF1C NCF1B	2.31e-06	3	31	2	26645958
Pubmed	Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation.	NCF1C NCF1B	2.31e-06	3	31	2	22050439
Pubmed	The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression.	NCF1C NCF1B	2.31e-06	3	31	2	12031896
Pubmed	Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.	NCF1C NCF1B	2.31e-06	3	31	2	12364355
Pubmed	NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion.	NCF1C NCF1B	2.31e-06	3	31	2	11249873
Pubmed	Ncf1 (p47phox) polymorphism determines oxidative burst and the severity of arthritis in rats and mice.	NCF1C NCF1B	2.31e-06	3	31	2	15936744
Pubmed	NADPH oxidase modulates myocardial Akt, ERK1/2 activation, and angiogenesis after hypoxia-reoxygenation.	NCF1C NCF1B	2.31e-06	3	31	2	17220182
Pubmed	NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis.	NCF1C NCF1B	2.31e-06	3	31	2	24549323
Pubmed	NADPH oxidase p47phox siRNA attenuates adventitial fibroblasts proliferation and migration in apoE(-/-) mouse.	NCF1C NCF1B	2.31e-06	3	31	2	25628043
Pubmed	NOX2-Deficient Neutrophils Facilitate Joint Inflammation Through Higher Pro-Inflammatory and Weakened Immune Checkpoint Activities.	NCF1C NCF1B	2.31e-06	3	31	2	34557202
Pubmed	Reactive Oxygen Species Regulate Both Priming and Established Arthritis, but with Different Mechanisms.	NCF1C NCF1B	2.31e-06	3	31	2	28467721
Pubmed	P47(phox)-deficient NADPH oxidase defect in neutrophils of diabetic mouse strains, C57BL/6J-m db/db and db/+.	NCF1C NCF1B	2.31e-06	3	31	2	10670582
Pubmed	NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity.	NCF1C NCF1B	2.31e-06	3	31	2	20881184
Pubmed	Regulated expression of TAF1 in 1-cell mouse embryos.	TAF1 TAF1L	2.31e-06	3	31	2	16822332
Pubmed	The p47phox mouse knock-out model of chronic granulomatous disease.	NCF1C NCF1B	2.31e-06	3	31	2	7650482
Pubmed	Direct Comparison of a Natural Loss-Of-Function Single Nucleotide Polymorphism with a Targeted Deletion in the Ncf1 Gene Reveals Different Phenotypes.	NCF1C NCF1B	2.31e-06	3	31	2	26528554
Pubmed	The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis.	NCF1C NCF1B	2.31e-06	3	31	2	19052348
Pubmed	Disseminated trichosporonosis in a murine model of chronic granulomatous disease.	NCF1C NCF1B	2.31e-06	3	31	2	12868577
Pubmed	Functional substitution for TAF(II)250 by a retroposed homolog that is expressed in human spermatogenesis.	TAF1 TAF1L	2.31e-06	3	31	2	12217962
Pubmed	Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit.	NCF1C NCF1B	2.31e-06	3	31	2	12560337
Interaction	CD2 interactions	PSTPIP1 CD2AP SH3KBP1	4.65e-06	23	29	3	int:CD2
Interaction	CBLB interactions	ARHGEF7 CD2AP ASAP1 SH3KBP1	2.14e-05	115	29	4	int:CBLB
Cytoband	7q11.23	NCF1C NCF1B	1.97e-03	97	31	2	7q11.23
Cytoband	Ensembl 112 genes in cytogenetic band chr15q24	MAN2C1 PSTPIP1	3.10e-03	122	31	2	chr15q24
Cytoband	Ensembl 112 genes in cytogenetic band chr7q11	NCF1C NCF1B	1.44e-02	271	31	2	chr7q11
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ASAP2 ARHGEF7 MYO10 ASAP1	6.87e-05	206	20	4	682
GeneFamily	X-linked mental retardation\|Rho GTPase activating proteins\|BAR-PH domain containing	ASAP2 ASAP1	1.57e-04	17	20	2	1291
GeneFamily	ArfGAPs	ASAP2 ASAP1	6.01e-04	33	20	2	395
GeneFamily	Ankyrin repeat domain containing	ASAP2 HECTD1 ASAP1	2.28e-03	242	20	3	403
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGEF7 PREX2	2.39e-03	66	20	2	722
Coexpression	AIZARANI_LIVER_C13_LSECS_2	ANPEP ARHGEF7 MYO10 PREX2 ASAP1	1.91e-05	283	31	5	M39117
ToppCell	(5)_Dendritic_cell-(51)_cDC1\|(5)_Dendritic_cell / shred on Cell_type and subtype	LIPC PSTPIP1 ANPEP ASAP1	1.58e-06	123	31	4	d46cfdf8b3e561d8db33903207d5151cdb2a91d4
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIXDC1 P2RX1 ANPEP CFAP65	7.65e-06	183	31	4	07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIXDC1 P2RX1 ANPEP CFAP65	7.65e-06	183	31	4	5a936fb07074cec753bf19e3e3e52499605ea22c
ToppCell	10x5'-Liver-Myeloid_Dendritic-DC1\|Liver / Manually curated celltypes from each tissue	ASAP2 ANPEP PREX2 ASAP1	8.15e-06	186	31	4	e823529ffd06352c6bdec102f221fdf27f7c7369
ToppCell	COPD-Stromal-Pericyte\|Stromal / Disease state, Lineage and Cell class	ARHGEF7 MYO10 ASAP1 FAM182B	8.33e-06	187	31	4	406ecd1dabb3ed8d871aef159f7bd1e383434953
ToppCell	IPF-Stromal-Pericyte\|Stromal / Disease state, Lineage and Cell class	ARHGEF7 MYO10 PREX2 ASAP1	9.63e-06	194	31	4	3892b188f424ffb80f3c75a1b6709a21c1e1601d
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECTD1 MYO10 PREX2 ASAP1	9.63e-06	194	31	4	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	(1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells\|World / Stress and Cell class	ARHGEF7 MYO10 PREX2 CD2AP	9.82e-06	195	31	4	6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	ASAP2 MYO10 PREX2 ASAP1	1.00e-05	196	31	4	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PALM3 C3 ATP8A1	9.99e-05	130	31	3	6434d9106ccb38786dad36fab80163dfc07b6eb7
ToppCell	Control-Epithelial_airway\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	C3 ANPEP CFAP65	1.78e-04	158	31	3	35aee1c3b92169e73569331022833cb44ab7e7e8
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3\|TCGA-Skin / Sample_Type by Project: Shred V9	ATP8A1 MYO10 ASAP1	1.81e-04	159	31	3	fb222c42f66901852b01cec073ec0732245ee973
ToppCell	droplet-Spleen-SPLEEN-1m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C3 CARD10 FHIP1B	2.02e-04	165	31	3	b671c6a950e70f64776c2104baccb3dc2bb6a1ba
ToppCell	metastatic_Lymph_Node-Myeloid_cells-CD141+_DCs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	ANPEP PREX2 ASAP1	2.05e-04	166	31	3	9f14e3ef19d5903278c040be1c477501237173fa
ToppCell	PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LIPC P2RX1 ASAP1	2.36e-04	174	31	3	a3f4981b10afa9d41a1c66c7f98522a8a534f82b
ToppCell	PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LIPC P2RX1 ASAP1	2.36e-04	174	31	3	6cc108dde4b3f98a78a6040280f0d5e4aaa5bd75
ToppCell	PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LIPC P2RX1 ASAP1	2.36e-04	174	31	3	4b8bc5568e36031c8ecf001bb646809038c23919
ToppCell	normal_Pleural_Fluid-Myeloid_cells-CD141+_DCs\|normal_Pleural_Fluid / Location, Cell class and cell subclass	ANPEP PREX2 ASAP1	2.44e-04	176	31	3	195393b38f1335f2cb96125616d75c164a6026c2
ToppCell	cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO10 ASAP1 FAM182B	2.48e-04	177	31	3	68263456a3c93cd195b321b309ff59e156d732fe
ToppCell	cellseq2-Mesenchymal-Myocytic-Myocytic_1\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO10 ASAP1 FAM182B	2.48e-04	177	31	3	e415e448c37adc102d766235e9953dec32c021f1
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 PREX2 CD2AP	2.52e-04	178	31	3	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	normal_Lymph_Node-Myeloid_cells-CD141+_DCs\|normal_Lymph_Node / Location, Cell class and cell subclass	ASAP2 ANPEP ASAP1	2.56e-04	179	31	3	ec995ccd6e1dbd06287ad836c232d9aed1cf94a8
ToppCell	PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DIXDC1 P2RX1 ASAP1	2.56e-04	179	31	3	362c003503190dc272fa89185a83a65e063d7a67
ToppCell	PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DIXDC1 P2RX1 ASAP1	2.56e-04	179	31	3	7d2e6bde00a9ab4cb21bd48b140ce205e36f9d77
ToppCell	PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DIXDC1 P2RX1 ASAP1	2.56e-04	179	31	3	e0eec8d48868c76c3e879f219357c62ceff1bc76
ToppCell	AT2_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	PALM3 C3 LIPC	2.65e-04	181	31	3	ed0ea67f0607073aedf153f8d1073b35e46127c3
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD2AP ASAP1 SH3KBP1	2.69e-04	182	31	3	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 ANPEP ARHGEF7	2.69e-04	182	31	3	ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9
ToppCell	10x5'-lymph-node_spleen-Myeloid_Dendritic-DC1\|lymph-node_spleen / Manually curated celltypes from each tissue	ASAP2 ANPEP ASAP1	2.74e-04	183	31	3	c9e3d91f4c3395a73295b92e25608e0effb5d241
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	C3 ATP8A1 CD2AP	2.78e-04	184	31	3	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 ANPEP ARHGEF7	2.78e-04	184	31	3	94748f63947db79a6b4540e3090a63689fdd9452
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 ANPEP ARHGEF7	2.78e-04	184	31	3	819b277ecced7b415e363c7e7ddbc6f3b2d296de
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD2AP ASAP1 SH3KBP1	2.82e-04	185	31	3	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c5-WDR74\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CARD10 P2RX1 ANPEP	2.82e-04	185	31	3	68edb1bb03ed221d49e583123ca4de14252d7bc5
ToppCell	droplet-Thymus-nan-24m-Myeloid-Plasma_cells_and_B_cells\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PALM3 LIPC ERLEC1	2.82e-04	185	31	3	e583f6601f9ed79b0b23d2f9426a4ba8b969230b
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_pDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	P2RX1 ARHGEF7 CD2AP	2.82e-04	185	31	3	308a98f111895071d8772bc010554471cc12fab2
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 PREX2 CD2AP	2.87e-04	186	31	3	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDAN1 ASAP2 MYO10	2.87e-04	186	31	3	4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8
ToppCell	droplet-Tongue-nan-24m-Epithelial-parabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSTPIP1 ANPEP SH3KBP1	2.87e-04	186	31	3	18c06041c6c8a0ebac17b3c8aaebd67e652d315a
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGEF7 MYO10 PREX2	2.87e-04	186	31	3	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-endo_venous_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CARD10 ATP8A1 ANPEP	2.92e-04	187	31	3	03de3c2df31bca0dc4e3718bada708d8fe8b69b9
ToppCell	E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ASAP2 PREX2 CD2AP	2.96e-04	188	31	3	59f276e23c8380bae57d7ecca3a8b83df4bc150b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PSTPIP1 ATP8A1 SH3KBP1	3.01e-04	189	31	3	b87d586a9570fa54f3e0c6bd4731c5badcaedae6
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C3 MYO10 PREX2	3.01e-04	189	31	3	42ab4cc5fbf8580841f31889446fe4499df1a464
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PSTPIP1 ATP8A1 SH3KBP1	3.01e-04	189	31	3	823d6debd09e440ddf36c54af24a5f20e222a21e
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PSTPIP1 ATP8A1 SH3KBP1	3.01e-04	189	31	3	47c2b419b081d5bf75da5e3d9a0e05a70362dfe7
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	DIXDC1 ARHGEF7 MYO10	3.01e-04	189	31	3	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PSTPIP1 P2RX1 ANPEP	3.05e-04	190	31	3	ad297172a74a80ed5c10f921e15efd1da0fd2d6b
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	ASAP2 ARHGEF7 PREX2	3.05e-04	190	31	3	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ASAP2 PREX2 CD2AP	3.05e-04	190	31	3	d87b9e9ca863270a9c7f61674271a6440c97d1f4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	C3 NCF1C NCF1B	3.10e-04	191	31	3	7d00796459f4ff0ab7f06a8379b2d34e76b078b2
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	MYO10 PREX2 ASAP1	3.10e-04	191	31	3	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NCF1C NCF1B ASAP1	3.10e-04	191	31	3	d4f77c73311d1149466bbfe4adbd6a301946ec90
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C3 MYO10 PREX2	3.10e-04	191	31	3	a90c8ab2077e52bbc998457c85a1b9867f9c8c93
ToppCell	IPF-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	C3 ATP8A1 ANPEP	3.15e-04	192	31	3	356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ASAP2 PREX2 CD2AP	3.15e-04	192	31	3	285a9d332a1e07b94f222d4b518dd56928b9e075
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ASAP2 HECTD1 CD2AP	3.15e-04	192	31	3	2510f22197502f60fd266b7f42eff040f25b8ae7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ASAP2 HECTD1 CD2AP	3.15e-04	192	31	3	e8e316f396834bcd34843e56e1d86f310fd6aada
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NCF1C NCF1B ASAP1	3.20e-04	193	31	3	e1855cff9a6bcfda9188b9fdf6c9d698405da990
ToppCell	wk_15-18-Hematologic-Myeloid-DC1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PSTPIP1 ANPEP ASAP1	3.20e-04	193	31	3	df9a4a459af51c2040ad832b580c333a135e374e
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	ASAP2 CD2AP ASAP1	3.20e-04	193	31	3	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-parabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSTPIP1 ANPEP SH3KBP1	3.20e-04	193	31	3	55eab7d2574e9cc2ed8f08e0a7ca7cbf90fb5818
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	FHIP1B ZNF569 MYO10	3.25e-04	194	31	3	8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DIXDC1 LIPC ANPEP	3.25e-04	194	31	3	70185c0b8e0f4e896645b17a243482ba3cdf4a5d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	P2RX1 ANPEP NCF1C	3.30e-04	195	31	3	d53585715c7f5827c4f5a6db11cb31857ee9d4f0
ToppCell	BAL-Severe-cDC_11\|Severe / Compartment, Disease Groups and Clusters	ANPEP PREX2 ASAP1	3.30e-04	195	31	3	2d31a1c2878c86a49a278b6c7decafabf26c3a5c
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-C\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ANPEP NCF1C NCF1B	3.30e-04	195	31	3	de47651c84da62f273535fc80115f0154746699d
ToppCell	facs-Heart-RA-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASAP2 MYO10 PREX2	3.30e-04	195	31	3	30c75761079fa1e1a3b84d23c88a222f459d5ce5
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CARD10 ASAP2 PREX2	3.34e-04	196	31	3	915e4a7422058be246b54760df31e8a607310625
ToppCell	droplet-Tongue-nan-3m-Epithelial-parabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSTPIP1 ANPEP SH3KBP1	3.34e-04	196	31	3	159061fd0961b2cfb5941d403acc5b395dd0d3a0
ToppCell	distal-Hematologic-Interstitial_Macrophage-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ANPEP NCF1C NCF1B	3.34e-04	196	31	3	e4f40274df940e0996c555082f2bb4f99e5b0881
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PALM3 C3 ANPEP	3.40e-04	197	31	3	01e9505d947e5a5f005d1eab96301f84fc194809
ToppCell	moderate-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	C3 ANPEP ERLEC1	3.45e-04	198	31	3	7ecce5e266bb08797088cc8f8309e0c7b48df5c9
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	C3 ATP8A1 ERLEC1	3.45e-04	198	31	3	d12f37527399038a8f030b45b176bda5c7c8a7ad
ToppCell	Control_saline-Epithelial_airway-airway_epithelial\|Control_saline / Treatment groups by lineage, cell group, cell type	C3 ANPEP CFAP65	3.45e-04	198	31	3	e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCell	Control_saline-Epithelial_airway\|Control_saline / Treatment groups by lineage, cell group, cell type	C3 ANPEP CFAP65	3.45e-04	198	31	3	e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	C3 ATP8A1 CD2AP	3.45e-04	198	31	3	82bcd44f8744e7e8477fbfd871a52f3d1a8b3adc
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CARD10 MYO10 PREX2	3.45e-04	198	31	3	1e83bec16dcd60460422625f89952ff506d6be51
ToppCell	10x3'2.3-week_17-19-Endothelial\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CARD10 MYO10 PREX2	3.45e-04	198	31	3	2630a7a6e56febe5c0b0bde70dd7292fa1650c47
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Airway-Club\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	C3 ANPEP CFAP65	3.50e-04	199	31	3	8649c2380285a668782d75eb076ce548eed0911d
ToppCell	Skin-Fibroblasts\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	C3 LIPC ANPEP	3.55e-04	200	31	3	f777eadf571a1a6d246da87346a9cb9d511c2e81
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	C3 ATP8A1 CD2AP	3.55e-04	200	31	3	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / Treatment groups by lineage, cell group, cell type	C3 ATP8A1 CD2AP	3.55e-04	200	31	3	9a6ae40f3e17cd44ee5fd73260713b920aa2ea15
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	C3 PSTPIP1 NCF1C	3.55e-04	200	31	3	5f1de1f9305e1784c12d526f6c8bdd7d56229f9b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ANPEP NCF1C NCF1B	3.55e-04	200	31	3	851c57187db8bc91a393655bca5f13e787a723d4
ToppCell	(51)_cDC1\|World / shred on Cell_type and subtype	LIPC ANPEP ASAP1	3.76e-04	204	31	3	a8cf4180c406674b7541917d1fc6127686ba5f8a
Drug	Mfpa	TAF1 TAF1L	5.38e-06	3	31	2	CID003035615
Disease	nephrotic syndrome (implicated_via_orthology)	LIPC CD2AP SH3KBP1	1.89e-06	24	30	3	DOID:1184 (implicated_via_orthology)
Disease	chronic granulomatous disease (implicated_via_orthology)	NCF1C NCF1B	9.97e-06	5	30	2	DOID:3265 (implicated_via_orthology)
Disease	tauopathy (implicated_via_orthology)	CD2AP SH3KBP1	4.47e-05	10	30	2	DOID:680 (implicated_via_orthology)
Disease	rheumatoid arthritis (implicated_via_orthology)	NCF1C NCF1B	6.55e-05	12	30	2	DOID:7148 (implicated_via_orthology)
Disease	end stage renal disease (implicated_via_orthology)	LIPC CD2AP	1.88e-04	20	30	2	DOID:783 (implicated_via_orthology)
Disease	Insulin Sensitivity	C3 LIPC	1.71e-03	60	30	2	C0920563
Disease	Insulin Resistance	C3 LIPC	1.71e-03	60	30	2	C0021655
Disease	atrophic macular degeneration, age-related macular degeneration, wet macular degeneration	C3 LIPC	1.71e-03	60	30	2	EFO_0001365, EFO_0004683, EFO_1001492
Disease	age-related macular degeneration, COVID-19	C3 LIPC	2.25e-03	69	30	2	EFO_0001365, MONDO_0100096

Protein segments in the cluster

Peptide	Gene	Start	Entry
EEEEEENVIGNWFWE	BHLHB9	166	Q6PI77
VVVGTWNQEEHIEWA	ERLEC1	376	Q96DZ1
WVQVPAHEWGHAEEL	CARD10	986	Q9BWT7
PGWEGKIVAWVEEDH	DIXDC1	666	Q155Q3
IIGKDTWVEHWPEED	C3	1621	P01024
IHVTRVEEGGWWEGT	ARHGEF7	211	Q14155
IAQGGEEEWDFAWEQ	ANPEP	801	P15144
DINEEVEEGWWSGTL	CD2AP	136	Q9Y5K6
EVLREWEDHHEEPGW	CDAN1	461	Q8IWY9
GAWEIVHWEKVAVGE	ATP8A1	141	Q9Y2Q0
WVKEDRGIVEVVWEG	PALM3	266	A6NDB9
TWQLQWDELGDGVEE	FHIP1B	111	Q8N612
LEVILEGEDGWWTVE	PSTPIP1	386	O43586
IIVDGEEDQEWWIGH	ASAP2	971	O43150
EEDQEWWIGHIDGDP	ASAP2	976	O43150
VIWGIEVAEELHWKG	CFAP65	141	Q6ZU64
REGLVWEDIDWIDNG	MYO10	476	Q9HD67
IIHGWSVDGVLENWI	LIPC	86	P11150
GEAVEVIHKLLDGWW	NCF1B	251	A6NI72
GEAVEVIHKLLDGWW	NCF1C	226	A8MVU1
WNVEEEEHEVGICTW	FAM182B	11	Q5T319
VTGELHNGWIDVTWD	HECTD1	1301	Q9ULT8
GEVIIVTGEEDQEWW	ASAP1	1091	Q9ULH1
VTGEEDQEWWIGHIE	ASAP1	1096	Q9ULH1
DQEWWIGHIEGQPER	ASAP1	1101	Q9ULH1
EVHLCWESDGEGLVW	MAN2C1	96	Q9NTJ4
GVVGITIDWHCDLDW	P2RX1	251	P51575
AEEEEVIIGSWFWEE	GPRASP1	836	Q5JY77
QLHWEDSIIWDGEDI	TAF1L	426	Q8IZX4
TQLHWEDDIIWDGED	TAF1	406	P21675
EVVGEVEEGWWEGVL	SH3KBP1	126	Q96B97
RHGIIVDWDTVQDIW	ACTL7A	136	Q9Y615
LEVLEEWQSHIEGWE	PREX2	221	Q70Z35
WLPGDEIDWETENHD	ZMYND11	86	Q15326
RHWQGEIWGVDEHQK	ZNF569	76	Q5MCW4